Cancer patients will receive an electronic larynx for the first time in SUS-MG

Patients with laryngeal cancer who have undergone complete removal of the organ and loss of the vocal cords will be able to speak again using an electronic larynx at the Alberto Cavalcanti Hospital (HAC), in Padre Eustacchio, in Belo Horizonte. This is the first time that the SUS Hospital in Minas Gerais has provided the tool. The event is part of Green July – Head and Neck Cancer Awareness Month – and will benefit eight people.

Laryngeal cancer is one of the most common diseases of the head and neck regions, accounting for 25% of cases. At HAC alone, an average of more than 2,000 consultations have taken place in the past five years. In the first six months of this year, 250 laryngeal cancer consultations took place.

When the disease enters an advanced stage, a complete laryngectomy is recommended, that is, surgery that removes the patient’s larynx and vocal cords. In this way, the person loses his ability to speak.

How does the electronic larynx work?

An electronic larynx is a portable device – with rechargeable batteries – that emits a continuous sound wave when placed on the neck, converting it into a sound that is articulated in the oral cavity, allowing communication. The device can be used a few days after the surgical treatment.

Use of the device seeks to facilitate communication and the emotional and social difficulties faced by patients, while favoring their return to daily activities.

new cases

Data from the National Cancer Institute (Inca) show that about 40,000 new cases of head and neck cancer are registered in Brazil each year. For this year alone, approximately 8,000 new cases of laryngeal cancer are expected in the country. Only in Minas Gerais 900 new cases.